Literature DB >> 22366776

Inflation in the number of eligibility criteria for industry-sponsored phase II cancer clinical trial: illustration over a 20-year period.

Stéphanie Clisant, Aurélie Clermont, Antoine Adenis, Nicolas Penel.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22366776     DOI： 10.1016/j.cct.2012.02.009

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN： 1551-7144            Impact factor:   2.226


× No keyword cloud information.
  3 in total

1.  Low clinical adoption of tumor genomic profiling: cause for concern?

Authors:  Michael W Drazer; Randy F Sweis
Journal:  J Med Econ       Date:  2018-05-15       Impact factor: 2.448

2.  The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies.

Authors:  Joseph M Unger; Elise Cook; Eric Tai; Archie Bleyer
Journal:  Am Soc Clin Oncol Educ Book       Date:  2016

3.  Survival of patients newly diagnosed with colorectal cancer and with a history of previous cancer.

Authors:  Sandi L Pruitt; David E Gerber; Hong Zhu; Daniel F Heitjan; Bhumika Maddineni; Danyi Xiong; Amit G Singal; Anna Tavakkoli; Ethan A Halm; Caitlin C Murphy
Journal:  Cancer Med       Date:  2021-06-30       Impact factor: 4.452
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.